Author(s)

E. O. Jimmy

Department of Human Physiology, Faculty of Basic Medical Sciences, University of Uyo, Uyo, Nigeria.

Effects of fansidar in alloxan-induced diabetes were investigated in thirty (30) male and female albino rats for 28 days. The results showed a steady weekly decrease in blood glucose concentration in induced diabetic rats after fansidar treatment. In week 1, i.e. 7 days, there was significant difference in the blood glucose levels between the control and diabetic rats (P < 0.05) i.e. high glucose concentration, same in week II i.e. 14 days. However, in day 21 i.e. week III there was a significant reduction in the blood glucose concentration compared with control P < 0.05. The same results were obtained in week IV i.e. in 28 days treatment. The result has shown that fansidar has antidiabetic potentials on long term durational administration.

Durational Dosage, Diabetes, Antidiabetic Potentials

Jimmy, E. (2019) Durational Therapeutic Dose of Fansidar: A Functional Index in Its Antidiabetic Properties. Journal of Biosciences and Medicines, 7, 23-28. doi: 10.4236/jbm.2019.71003.